Skip to main content
SpringerLink
Log in

Meaningful interpretation of clinical trials requires careful consideration of their findings

  • Practical Issues and Updates
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

References

  1. Tsong Y. The utility of active-controlled noninferiority/equivalence trials in drug development. Int J Pharm Med 2007; 21(3): 225–33

    Article  Google Scholar 

  2. Pigeot I, Schäfer J, Röhmel J, et al. Assessing non-inferiority of a new treatment in a three-arm clinical trial including a placebo. Stat Med 2003; 22(6): 883–99

    Article  PubMed  Google Scholar 

  3. ICH harmonised tripartite guideline. Statistical principles for clinical trials: E9 [online]. Available from URL: http://www.ich.org [Accessed 2007 Dec 15]

  4. ICH harmonised tripartite guideline. Choice of control group and related issues in clinical trials: E10 [online]. Available from URL: http://www.ich.org [Accessed 2007 Dec 15]

  5. Kleist P. Composite endpoints for clinical trials: current perspectives. Int J Pharm Med 2007; 21(3): 187–198

    Article  Google Scholar 

  6. Committee for Proprietary Medicinal Products (CPMP). Points to consider on multiplicity issues in clinical trials. CPMP/EWP/908/ 99. London, 19 Dec 2002 [online]. Available from URL: http://www.emea.europa.eu [Accessed 2007 Dec 15]

  7. Chi GYH. Some issues with composite endpoints in clinical trials. Fundam Clin Pharmacol 2005; 19(6): 609–19

    Article  PubMed  CAS  Google Scholar 

  8. Lauer MS, Topol EJ. Clinical trials: multiple treatments, multiple end points, and multiple lessons. JAMA 2003; 289(19): 2575–7

    Article  PubMed  Google Scholar 

  9. Weatherall M, Burgess C, Taylor W. Open-label extension studies: interpretation and statistical issues. Int J Pharm Med 2007; 21(2): 115–20

    Article  Google Scholar 

  10. Golombek SG, van den Anker J, Rose K. Clinical trials in children: ethical and practical issues. Int J Pharm Med 2007; 21(2): 121–9

    Article  Google Scholar 

  11. The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research [online]. Available from URL: http://ohsr.od.nih.gov [Accessed 2007 Dec 15]

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Meaningful interpretation of clinical trials requires careful consideration of their findings. Drugs Ther. Perspect 24, 23–26 (2008). https://doi.org/10.2165/00042310-200824030-00008

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200824030-00008

Keywords

Search

Navigation